How effective is Cellcept for Systemic Lupus Erythematosus? (a real world drug study)
Summary:
Overall ratings: 3.3/5 Long term ratings: 3.6/5
This is a phase IV clinical study of how effective Cellcept (mycophenolate mofetil) is for Systemic lupus erythematosus and for what kind of people. The study is created by eHealthMe from 72 Cellcept users and is updated continuously.
What is Cellcept?
Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.
What is Systemic lupus erythematosus?
Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 1,089 drugs and 1,641 conditions by eHealthMe. Check the latest studies of Systemic lupus erythematosus.
72 people are studied for taking Cellcept in Systemic lupus erythematosus
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Cellcept effectiveness for Systemic lupus erythematosus (number of people):
Overall:
- not at all: 4
- somewhat: 15
- moderate: 16
- high: 29
- very high: 8
Long Term:
- not at all: 0
- somewhat: 4
- moderate: 13
- high: 15
- very high: 6
Gender of people who take Cellcept for Systemic lupus erythematosus *:
- female: 91.67 %
- male: 8.33 %
Age of people who take Cellcept for Systemic lupus erythematosus *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 2.7800000000000002 %
- 20-29: 11.11 %
- 30-39: 13.89 %
- 40-49: 34.72 %
- 50-59: 25.0 %
- 60+: 12.5 %
Who find Cellcept more effective for Systemic Lupus Erythematosus?
Gender of people who take Cellcept for Systemic lupus erythematosus *:
- female: 91.89 %
- male: 8.11 %
Age of people who take Cellcept for Systemic lupus erythematosus *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 5.41 %
- 20-29: 16.22 %
- 30-39: 13.51 %
- 40-49: 24.32 %
- 50-59: 29.73 %
- 60+: 10.81 %
* Approximation only. Some reports may have incomplete information.
Do you take Cellcept?
- You can start a phase IV clinical trial to monitor Cellcept safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
- Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
Related studies
Alternative drugs to, pros and cons of:
- Cellcept (41,872 reports)
Treatments, associated drugs and conditions:
- Systemic lupus erythematosus (76,947 reports)
How the study uses the data?
The study is based on mycophenolate mofetil (the active ingredients of Cellcept) and Cellcept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Caffeine vs. Niacin, side effect and effectiveness comparison - 3 seconds ago
- Drug interactions of Metformin and Differin - 8 seconds ago
- Could Clotrimazole cause Herpes Zoster? - 13 seconds ago
- Drug interactions of Sevoflurane and Propofol - 14 seconds ago
- Could Renvela cause Renal Failure Chronic Aggravated? - 14 seconds ago
- Could Asacol cause Haemorrhage? - 15 seconds ago
- Osteoporosis Post-Menopausal and Acute Phase Reaction - 15 seconds ago
- Drug interactions of Depakote and Metformin - 16 seconds ago
- Could Botox cause Cyst? - 18 seconds ago
- Could Equanil cause Fever? - 20 seconds ago